On-treatment modified Glasgow Prognostic Score (mGPS) in hepatocellular carcinoma treated with atezolizumab and bevacizumab provides prognostic information.
Frontiers in immunology
View this publicationFrontiers in immunology
View this publicationScientific reports
View this publicationThe World Allergy Organization journal
View this publicationImmunology letters
View this publicationScientific reports
View this publicationSTAR protocols
View this publicationScience translational medicine
View this publicationInternational journal of stroke : official journal of the International Stroke Society
View this publicationInterdisciplinary cardiovascular and thoracic surgery
View this publicationScientific reports
View this publication